Rapid developments in innovative urinary incontinence devices and increase in urological disorders among the geriatric population drive the growth of the global urinary incontinence devices market.
The factors that propel the growth of the global Electroceuticals/Bioelectrical Medicine Market include high-tech advancements, increase in disposable income, increasing incidences of hearing loss, expanding geriatric population, development of new therapies, rising prevalence of neurological disorders, and increasing capital investment.
The majority of women who undergo surgery for suspected ovarian cancer do not actually have the disease, but these unnecessary surgeries could soon be reduced thanks to a novel blood test developed by a Swedish research team.
Patients with paralysis-related speech loss could benefit from a new technology developed by University of California San Francisco (UCSF) researchers that turns brain signals for speech into written sentences.
Researchers at Heriot-Watt University in Edinburgh, Scotland are developing smart sensors which can monitor the healing progress of a wound, eliminating the need to look underneath a bandage.
Siemens Healthineers has signed a definitive agreement to acquire all fully diluted shares of US-based Corindus Vascular Robotics.
The deal is valued at $4.28 per share in cash or $1.1bn in total.
Corindus develops, produces and sells robotic systems for minimally invasive procedures, while Siemens' products use quality imaging before and during medical interventions to make minimally invasive treatment possible.
In this article, we'll go over a list of advancing technologies in the healthcare industry. Read them all carefully to gain a thorough understanding of future and existing healthcare trends in 2021.
Telehealth is a one-stop-shop solution for a wide range of healthcare services that is convenient and time-saving. So, here we are, sharing all about Telehealth within this quick guide.
Despite advances in the renal cell carcinoma (RCC) therapy landscape, the majority of patients with RCC will eventually develop resistance to available therapies and the disease will progress through several stages, requiring further lines of treatment.
Cancer Research UK has announced a £56m research network to transform the UK into a global hub for radiotherapy study.
By leveraging the use of the latest techniques, such as FLASH radiotherapy and artificial intelligence (AI), the network aims to accelerate the development of advanced radiotherapy.
Food Colorants will continue to grow due to the increasing disposable income among developing countries, raising awareness about health, and changing trends about aesthetics. The global food colorants market is projected to grow at a CAGR of 5.2% during the forecast period to reach a value of $5.3 billion by 2023.
Food colorants are widely being used because of their added efficiency in various applications. The added synthetic or natural colorants make the food or beverage to be more attractive and luring. The natural colorants are in demand owing to their health benefits as well.
the "Global Lung Cancer Drugs Market" will grow at a CAGR of 13.6% during the forecast period. The market has witnessed steady growth in the past few years with the introduction of novel products, which have augmented the acceptance of immunotherapy drugs in the market. The market is fueled by upsurge in the incidence of lung cancer cases across the globe - owing to increasing diagnosis rate and mainly due to increasing tobacco consumption, increase in the lung cancer treatment rates, increasing rate of effective drug approvals as first-line therapies, strategic deals to develop new products, increasing R&D spending, and rapid industrialization leading to increased pollution.
The report provides complete details about the sub-segments of the lung cancer drugs market. Through this report, the key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, and government initiatives towards the disease management in the upcoming years along with details of the existing pureplay companies and new players entering the market.
The global market for chronic kidney disease drugs is expected to witness single-digit growth during 2019-2025. The drug pipeline of chronic kidney disease looks promising with novel therapeutic approaches, such as cell therapy, likely to enhance the market growth opportunities. However, the competition from biosimilars and complex drug development processes are impeding the market growth.
Over the period, extensive research is being done to fill the unmet needs' gap. The advances in the arena of regenerative treatment have come up with budding advancement of cell therapies that help regeneration and repairing of the kidneys. Cell therapy is proficient of refining the fundamental functioning capability of the kidney. Uncontrolled high blood pressure and diabetes are the leading causes of kidney failure globally.
Infoholic's market research report predicts that the global leukemia therapeutics market will grow at a CAGR of 6.2% during the forecast period 2019-2025. Leukemia refers to the group of blood cancer that usually develops in the bone marrow, resulting in the formation of abnormal blood cells. Leukemia is subdivided into lymphoblastic or lymphocytic leukemias and myeloid or myelogenous leukemias that include acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML).
The report provides complete details about the sub-segment of the global leukemia therapeutics market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
Cardiovascular disease is a significant health concern worldwide despite having many genomics developments providing valuable new candidates for better biomarkers and novel therapeutic targets.
Surgical robots are designed to do much more than simple surgeries, including complex surgeries that are usually only done under very complicated circumstances. For example, a surgical robot that is used to help urologists insert hyaluronic acid pellets into the penis is able to perform this surgery without placing the patient at risk for any kind of infection.
Growing demand awareness regarding the advantages of robotic-assisted surgery coupled with the advancement in the surgery is fueling the market growth of surgical robots. Increasing adoption of surgical robots across hospitals & ambulatory surgery centers in order to reduce human error and improve patient safety is again driving the market growth of surgical robots. According to the International Federation of Robotics, the total value of sales of medical robots increased to US$1.9 billion, accounting for 29 percent of the total sales value of the professional service robots in 2017. Moreover, expanding application of surgical robots across various surgeries such as general surgery, gynecological surgery, urological surgery, neurosurgery, orthopedic surgery, and other applications is also expected to uplift the market growth. Growing focus on improving surgeries with better precision and outcome is further anticipated to bolster the market growth of surgical robots. A rise in the funding in the field of surgical robots for developing more advanced cost-effective robots is anticipated to foster the market growth of the surgical robots.
Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/surgical-robots-addresses-complex.html